Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher Kelly

Physician Assistant Gilbert, WV Physician Assistant

NPI 1407137110 CMS profile 10589089

202 Larry Joe Harless Dr., Gilbert, WV 25621

Open in the dashboard

General payments

$765

42 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Kelly of Gilbert, WV is reported in the CMS Open Payments database as having received $765 across 42 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 63rd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $192 10
2024 General $91 5
2023 General $125 7
2022 General $119 7
2021 General $239 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Kelly
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Christopher Kelly were reported at $192. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Christopher Kelly Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $239 $132 $37–$438 $132
2022 $119 $155 $48–$522 $149
2023 $125 $167 $52–$557 $160
2024 $91 $178 $55–$600 $164
2025 $192 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $206 11 payments
  2. Novo Nordisk Inc $114 6 payments
  3. AstraZeneca Pharmaceuticals LP $76 4 payments
  4. Abbott Laboratories $67 3 payments
  5. Novartis Pharmaceuticals Corporation $58 3 payments
  6. AbbVie, Inc. $37 2 payments
  7. Nevro Corp. $36 2 payments
  8. Pfizer Inc. $33 2 payments
  9. Merck Sharp & Dohme Corporation $26 2 payments
  10. Bayer HealthCare Pharmaceuticals Inc. $20 1 payment
  11. Other $92 6 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $745 41 payments
  2. Education $20 1 payment
Products named General payments · program years 2021–2025
  1. JARDIANCE $191 10 payments
  2. SYNJARDY $125 6 payments
  3. RYBELSUS $79 4 payments
  4. Ozempic $79 4 payments
  5. FreeStyle Libre 2 $67 3 payments
  6. TRADJENTA $37 2 payments
  7. AIRSUPRA $37 2 payments
  8. Omnia $36 2 payments
  9. LEQVIO $35 2 payments
  10. ENTRESTO $35 2 payments
  11. Other $327 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 175 drugs

Part D claims

11,906

Median for Physician Assistant: 241

Drug cost

$1,792,064

Median for Physician Assistant: $4,110

Branded share of claims

25.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ozempic Semaglutide Brand 134 $216,161
Mounjaro Tirzepatide Brand 149 $215,628
Farxiga Dapagliflozin Propanediol Brand 141 $173,538
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 87 $118,987
Repatha Sureclick Evolocumab Brand 93 $78,708
Entresto Sacubitril/Valsartan Brand 61 $73,773
Eliquis Apixaban Brand 61 $67,498
Tresiba Flextouch U-200 Insulin Degludec Brand 33 $60,759
Xarelto Rivaroxaban Brand 36 $56,197
Tradjenta Linagliptin Brand 48 $51,175

The 10 drugs with the highest cost, of 175 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$1,035

Medicare's payments for the services billed

Medicare patients

29

Average age 69

Services billed

36

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Diabetes 75%
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 48%
Chronic kidney disease 48%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JARDIANCE
  • Lilly USA, LLC $17
$17 15 —
VRAYLAR
  • AbbVie, Inc. $16
$16 — —
TRELEGY ELLIPTA
  • GlaxoSmithKline, LLC. $14
$14 87 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

42 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record